391 related articles for article (PubMed ID: 12566304)
21. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
22. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
Gibson EM; Henson ES; Haney N; Villanueva J; Gibson SB
Cancer Res; 2002 Jan; 62(2):488-96. PubMed ID: 11809700
[TBL] [Abstract][Full Text] [Related]
24. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1.
Soh JW; Mao Y; Kim MG; Pamukcu R; Li H; Piazza GA; Thompson WJ; Weinstein IB
Clin Cancer Res; 2000 Oct; 6(10):4136-41. PubMed ID: 11051267
[TBL] [Abstract][Full Text] [Related]
25. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
Rice PL; Kelloff J; Sullivan H; Driggers LJ; Beard KS; Kuwada S; Piazza G; Ahnen DJ
Mol Cancer Ther; 2003 Sep; 2(9):885-92. PubMed ID: 14555707
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage.
Zhu Y; Yang GY; Ahlemeyer B; Pang L; Che XM; Culmsee C; Klumpp S; Krieglstein J
J Neurosci; 2002 May; 22(10):3898-909. PubMed ID: 12019309
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
Hu Y; Bally M; Dragowska WH; Mayer L
Mol Cancer Ther; 2003 Jul; 2(7):641-9. PubMed ID: 12883037
[TBL] [Abstract][Full Text] [Related]
28. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.
Liang Q; Wiese RJ; Bueno OF; Dai YS; Markham BE; Molkentin JD
Mol Cell Biol; 2001 Nov; 21(21):7460-9. PubMed ID: 11585926
[TBL] [Abstract][Full Text] [Related]
29. Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells.
Besson A; Davy A; Robbins SM; Yong VW
Oncogene; 2001 Nov; 20(50):7398-407. PubMed ID: 11704869
[TBL] [Abstract][Full Text] [Related]
30. Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK.
Nishihara H; Hwang M; Kizaka-Kondoh S; Eckmann L; Insel PA
J Biol Chem; 2004 Jun; 279(25):26176-83. PubMed ID: 15078890
[TBL] [Abstract][Full Text] [Related]
31. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases.
Xiao D; Singh SV
Cancer Res; 2002 Jul; 62(13):3615-9. PubMed ID: 12097262
[TBL] [Abstract][Full Text] [Related]
32. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation.
Cameron SJ; Malik S; Akaike M; Lerner-Marmarosh N; Yan C; Lee JD; Abe J; Yang J
J Biol Chem; 2003 May; 278(20):18682-8. PubMed ID: 12637502
[TBL] [Abstract][Full Text] [Related]
33. cAMP potentiates H(2)O(2)-induced ERK1/2 phosphorylation without the requirement for MEK1/2 phosphorylation.
Lee K; Esselman WJ
Cell Signal; 2001 Sep; 13(9):645-52. PubMed ID: 11495722
[TBL] [Abstract][Full Text] [Related]
34. Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2.
Sinicrope FA; Penington RC
Mol Cancer Ther; 2005 Oct; 4(10):1475-83. PubMed ID: 16227396
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
[TBL] [Abstract][Full Text] [Related]
36. The mitogen-activated protein kinase cascade mediates neurotrophic effect of epidermal growth factor in cultured rat hippocampal neurons.
Abe K; Saito H
Neurosci Lett; 2000 Mar; 282(1-2):89-92. PubMed ID: 10713403
[TBL] [Abstract][Full Text] [Related]
37. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells.
Elder DJ; Halton DE; Playle LC; Paraskeva C
Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399
[TBL] [Abstract][Full Text] [Related]
38. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
39. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
[TBL] [Abstract][Full Text] [Related]
40. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
